cardiovascular

Lifeline
Biotech

After failed acquisition, Lisata finds lifeline in Marea merger

Alongside the stock-for-stock transaction that is bringing Lisata and Marea together, Lisata also announced a $225 million private placement.
Darren Incorvaia Sep 17, 2026 10:00am
Scotland medieval

Braveheart charges to $382.5M IPO to fund Hengrui cardio drug

Aug 6, 2026 8:27am
Red heart sewn into white fabric

Kardigan plans to bring in cozy $320M haul from upcoming IPO

Jun 11, 2026 8:14am
Red heart sewn into white fabric

Kardigan itching for IPO to fund late-stage cardio pipeline

May 27, 2026 4:57am
Stop sign and red lights at traffic intersection

Genentech shreds RIPK1 inhibitor after ph. 2 failure

Mar 19, 2026 2:48pm
MA

Lilly buys inflammation biotech Ventyx for $1.2B

Jan 8, 2026 7:01am